Recreational marijuana was given the nod of approval in four states on Tuesday (November 8), further boosting hopes of legalizing it across the United States.
While cannabis is already legal in California, the golden state voted in favor of recreational use, along with Nevada, Massachusetts and Maine. This also makes Massachusetts’ the first state east of Mississippi to allow recreational use of marijuana.
California’s approval of cannabis legalization, according to the L.A. Times, makes it the United States’ biggest market for marijuana products.
Nate Bradley, executive director of the California Cannabis Industry, told the Times that they are “very excited” about California’s approval of Proposition 64.
“Proposition 64 will allow California to take its rightful place as the center of cannabis innovation, research and development,” he said.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

To that end, the votes bring recreational cannabis usage legal to eight states: Colorado, Washington, Oregon and Alaska have previously dropped their laws against pot.
Other states, such as Florida, North Dakota, and Arkansas voted on marijuana measures to expand conditions that can be treated with cannabis. This effectively pushes the number of states with these specific regulations over two dozen.
According to New Frontier Data, in partnership with Arcview Market Research, the legalization of marijuana in the above-mentioned states projects the cannabis market to rise above $20.9 billion by 2020.
“Recent polls have shown 60 percent of the public supports adult use legalization,” Giadha DeCarcer, founder and CEO of New Frontier said in the press release.  “The passage of California’s adult use measure and Florida’s medical initiative expand legal access into two of the country’s most populous states. Additionally, the passage of the measure in Massachusetts opens the first adult use market in the Northeast extending the reach of legal adult use access from coast to coast.”
 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Still–there is lots of uncertainty surrounding cannabis legalization under a Trump Justice Department.
Ethan Nadelmann, executive director of the Drug Policy Alliance, expressed concerns in a statement over Donald Trump as the next president
“His most likely appointees to senior law enforcement positions — Rudy Giuliani and Chris Christie — are no friends of marijuana reform, nor is his vice president,” he continued.
While marijuana is legal across many states, it is still illegal for all uses under federal law. Back in 2013, the Obama administration put a policy in place for non-interference with state cannabis legalization.
Given that it’s early days yet, and as the country awaits Donald Trump to become president, the future is unclear as to what the laws will be on legalization of marijuana.

Cannabis stocks rising

On that note, cannabis stocks have been riding a high as a result of the election. Here’s a look at a few who have performed well following the votes to legalize marijuana.


  • Marapharm Ventures (CNSX:MDM)(OTCMKTS:MRPHF): the Las Vegas-based company has increased 44.29 percent over a one-day period to reach $1.04;
  • Pineapple Express (OTCMKTS:PNPL): up 35.71 percent to $4.75 over a one-day period;
  • Finore Mining (CNSX:FIN) (OTCMKTS:FNREF): the company has seen a slight increase of 2.38 percent for a one-day period to $0.297.

Don’t forget to follow us @INN_Cannabis  for real-time news updates.
Securities Disclosure: I, Jocelyn Aspa, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: Finore Mining is a client of the Investing News Network. This article is not paid for content.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less